Loading clinical trials...
Loading clinical trials...
FAPI PET has been developed as a promising approach for the evaluation of fibroinflammatory, such as in inflammatory bowel disease. This prospective study aims to explore the value of 18F-AlF-FAPI PET...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Peking University Third Hospital
NCT07262476 · Thyroid Eye Disease (TED)
NCT07423013 · Thyroid Eye Disease
NCT06112340 · Thyroid Eye Disease, Graves Orbitopathy, and more
NCT05012033 · Thyroid Eye Disease, Vasculitis, and more
NCT06557850 · Thyroid Eye Disease
Dept. of Nuclear Medicine, Peking University Third Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions